Theratechnologies Net debt/EBITDA
What is the Net debt/EBITDA of Theratechnologies?
The Net debt/EBITDA of Theratechnologies Inc. is -70.44
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to Theratechnologies
What does Theratechnologies do?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Companies with net debt/ebitda similar to Theratechnologies
- InvesTech has Net debt/EBITDA of -71.03
- Biotest AG has Net debt/EBITDA of -70.94
- Wan Kei has Net debt/EBITDA of -70.87
- Ecolomondo has Net debt/EBITDA of -70.79
- SHIS has Net debt/EBITDA of -70.52
- BQE Water has Net debt/EBITDA of -70.48
- Theratechnologies has Net debt/EBITDA of -70.44
- Time Watch Investments has Net debt/EBITDA of -70.28
- Boingo Wireless Inc has Net debt/EBITDA of -70.25
- CPS Technologies has Net debt/EBITDA of -70.04
- Boston Omaha Corp has Net debt/EBITDA of -69.98
- Cleantek Industries Inc has Net debt/EBITDA of -69.92
- Quorum Information Technologies has Net debt/EBITDA of -69.92